BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30153334)

  • 1. Prostate lesion delineation from multiparametric magnetic resonance imaging based on locality alignment discriminant analysis.
    Lin M; Chen W; Zhao M; Gibson E; Bastian-Jordan M; Cool DW; Kassam Z; Liang H; Chow TWS; Ward AD; Chiu B
    Med Phys; 2018 Oct; 45(10):4607-4618. PubMed ID: 30153334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A self-tuned graph-based framework for localization and grading prostate cancer lesions: An initial evaluation based on multiparametric magnetic resonance imaging.
    Chen W; Lin M; Gibson E; Bastian-Jordan M; Cool DW; Kassam Z; Liang H; Feng G; Ward AD; Chiu B
    Comput Biol Med; 2018 May; 96():252-265. PubMed ID: 29653354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a 5-Minute Magnetic Resonance Imaging Screening Protocol for Prostate Cancer in Men With Elevated Prostate-Specific Antigen Before Biopsy.
    Weiss J; Martirosian P; Notohamiprodjo M; Kaufmann S; Othman AE; Grosse U; Nikolaou K; Gatidis S
    Invest Radiol; 2018 Mar; 53(3):186-190. PubMed ID: 29077588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic stratification of prostate tumour aggressiveness using multiparametric MRI: a horizontal comparison of texture features.
    Sun Y; Reynolds HM; Wraith D; Williams S; Finnegan ME; Mitchell C; Murphy D; Haworth A
    Acta Oncol; 2019 Aug; 58(8):1118-1126. PubMed ID: 30994052
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review.
    Hassanzadeh E; Glazer DI; Dunne RM; Fennessy FM; Harisinghani MG; Tempany CM
    Abdom Radiol (NY); 2017 Jan; 42(1):278-289. PubMed ID: 27522352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?
    Huebner NA; Korn S; Resch I; Grubmüller B; Gross T; Gale R; Kramer G; Poetsch N; Clauser P; Haitel A; Fajkovic H; Shariat SF; Baltzer PA
    Eur Radiol; 2021 Jun; 31(6):3754-3764. PubMed ID: 33263793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI).
    Gatti M; Faletti R; Calleris G; Giglio J; Berzovini C; Gentile F; Marra G; Misischi F; Molinaro L; Bergamasco L; Gontero P; Papotti M; Fonio P
    Abdom Radiol (NY); 2019 May; 44(5):1883-1893. PubMed ID: 30788558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
    Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
    AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A deep dive into understanding tumor foci classification using multiparametric MRI based on convolutional neural network.
    Zong W; Lee JK; Liu C; Carver EN; Feldman AM; Janic B; Elshaikh MA; Pantelic MV; Hearshen D; Chetty IJ; Movsas B; Wen N
    Med Phys; 2020 Sep; 47(9):4077-4086. PubMed ID: 32449176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer segmentation from MRI by a multistream fusion encoder.
    Jiang M; Yuan B; Kou W; Yan W; Marshall H; Yang Q; Syer T; Punwani S; Emberton M; Barratt DC; Cho CCM; Hu Y; Chiu B
    Med Phys; 2023 Sep; 50(9):5489-5504. PubMed ID: 36938883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of locally radio-recurrent prostate cancer at multiparametric MRI: Can dynamic contrast-enhanced imaging be omitted?
    Alonzo F; Melodelima C; Bratan F; Vitry T; Crouzet S; Gelet A; Rouvière O
    Diagn Interv Imaging; 2016 Apr; 97(4):433-41. PubMed ID: 26928245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate MRI based on PI-RADS version 2: how we review and report.
    Steiger P; Thoeny HC
    Cancer Imaging; 2016 Apr; 16():9. PubMed ID: 27067275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI.
    Harvey H; Orton MR; Morgan VA; Parker C; Dearnaley D; Fisher C; deSouza NM
    Br J Radiol; 2017 Mar; 90(1071):20160416. PubMed ID: 28055249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
    Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
    Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an Automated Analysis Tool for Prostate Cancer Prediction Using Multiparametric Magnetic Resonance Imaging.
    Roethke MC; Kuru TH; Mueller-Wolf MB; Agterhuis E; Edler C; Hohenfellner M; Schlemmer HP; Hadaschik BA
    PLoS One; 2016; 11(7):e0159803. PubMed ID: 27454770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation.
    Israël B; Leest MV; Sedelaar M; Padhani AR; Zámecnik P; Barentsz JO
    Eur Urol; 2020 Apr; 77(4):469-480. PubMed ID: 31767492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automatic intraprostatic lesion segmentation in multiparametric magnetic resonance images with proposed multiple branch UNet.
    Chen Y; Xing L; Yu L; Bagshaw HP; Buyyounouski MK; Han B
    Med Phys; 2020 Dec; 47(12):6421-6429. PubMed ID: 33012016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier.
    Chan I; Wells W; Mulkern RV; Haker S; Zhang J; Zou KH; Maier SE; Tempany CM
    Med Phys; 2003 Sep; 30(9):2390-8. PubMed ID: 14528961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidimensional analysis of clinicopathological characteristics of false-negative clinically significant prostate cancers on multiparametric MRI of the prostate in Japanese men.
    Kido A; Tamada T; Kanomata N; Yamamoto A; Miyaji Y; Nagai A; Sone T
    Jpn J Radiol; 2019 Feb; 37(2):154-164. PubMed ID: 30600483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.
    Gibson E; Bauman GS; Romagnoli C; Cool DW; Bastian-Jordan M; Kassam Z; Gaed M; Moussa M; Gómez JA; Pautler SE; Chin JL; Crukley C; Haider MA; Fenster A; Ward AD
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):188-96. PubMed ID: 27375167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.